1. Aventis Pharma S.a. (21 from 377 patents)

2. Sanofi (12 from 1,456 patents)

3. Sanofi-A Ventis Deutschland Gmbh (6 from 1,832 patents)

4. Rhone-Poulenc Rorer S.a. (5 from 247 patents)

5. Sanofi-Aventis (1 from 389 patents)

1. 10980816 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

2. 10736904 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

3. 10500212 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

4. 10220044 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

5. 9744176 - Therapeutic uses of novel thienopyrimidine derivatives

6. 9221817 - Anti-cancer compound and pharmaceutical composition containing the same

7. 9221828 - N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals

8. 9133168 - Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors

9. 9115140 - Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof

10. 9073917 - Anti-cancer compound and pharmaceutical composition containing the same

11. 8993565 - (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

12. 8791255 - (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

13. 8163768 - 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them

14. 7884123 - Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof

15. 7772261 - [object Object]